Fundació Institut d'Investigació Sanitària Illes Balears

What Fundació Institut d'Investigació Sanitària Illes Balears does

Fundació Institut d'Investigació Sanitària Illes Balears (IdISBa), headquartered at Son Espases University Hospital (Building S, Valldemossa Highway 79, Palma de Mallorca, Balearic Islands, Spain), is a public foundation integrated as an instrumental entity within the Balearic Islands regional Ministry of Health (Conselleria de Salut). Founded in 2013/2015, IdISBa coordinates biosanitary, biomedical, and public-health research across the archipelago, serving the regional healthcare system, the University of the Balearic Islands (UIB), Son Espases and Son Llàtzer hospitals, the Blood and Tissue Bank of the Balearic Islands, and primary care services. The institute anchors 924 research staff, produces 574 indexed publications per year, and runs 123 active competitive research projects and 365 active clinical trials annually.

The institute's core product is an integrated research infrastructure comprising ten scientific-technical platforms — Biobank, Flow Cytometry and Cell Biology, Experimental Surgery and Animal Facility, Clinical Research and Clinical Trials Unit (UBICEC), Genomics and Bioinformatics, Microscopy, Proteomics, Health Information Research (PRISIB), Molecular Imaging and Mass Spectrometry (PT-IMEM), and Scientific and Technological Services — plus seven management areas covering project management, innovation, training, scientific management, infrastructure, economic-administrative, and knowledge and quality management. It also operates the UITRI Technology Transfer Unit (spin-offs, licensing, collaborative R&D) and a Training and Communication Area delivering continuous training, doctoral theses support, mobility programmes, and training internships.

IdISBa does not operate a conventional commercial revenue model. Its "business model" is a public-foundation hybrid: base institutional funding from the Conselleria de Salut; competitive project grants from Spanish national bodies (Instituto de Salud Carlos III, Ministry of Science, Innovation and Universities, Ministry of Health) and the European Union (NextGenerationEU, ERDF, ESF); revenue from technology transfer (spin-offs, license agreements, collaborative R&D with healthcare companies); and ancillary training income (e.g., €200 general / €100 student fees for the 2026 Implementation Science Workshop). Distribution is direct-to-researcher via the institute's Research Portal (idisba.portalinvestigacion.com) and to companies via the Innovation Area; marketing is institutional-website-led with a monthly bulletin, social channels, events, and a public transparency portal. The institute was the first in the Balearic Islands to receive the European Commission's HR Excellence in Research award (2017), now part of a cohort of 170 Spanish institutions, and is executing its 2025-2029 Integration Plan formalizing R2/R3/R4 researcher tiers.

Name

Fundació Institut d'Investigació Sanitària Illes Balears

Legal name

Fundació Institut d'Investigació Sanitària Illes Balears

Website

https://idisba.es

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

IdISBa is a Balearic Islands public research foundation coordinating regional biosanitary and biomedical research across 924 staff, 10 scientific-technical platforms, 123 active projects, and 365 active clinical trials, serving the regional health system, UIB, and consortium hospitals under the Conselleria de Salut.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)

Keywords

• Biomedical research services
• Clinical trials infrastructure
• Health research platforms
• Translational medicine research
• Scientific technical platforms

Headquarters

HQ city

Palma De Mallorca

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Others

Revenue model

1. Public Institutional Funding: IdISBa receives base funding as a public foundation of the Balearic Islands public health sector, under the regional Ministry of Health (Conselleria de Salut)
2. Competitive Research Projects: Funding through competitive project calls including European Union grants (NextGenerationEU, ERDF, ESF), national funding from ISCIII, and regional government sources
3. Innovation and Technology Transfer: Revenue generation through spin-off companies, license agreements, and collaborative R&D projects with the private healthcare sector
4. Training Services: Income from specialized training activities, courses, and doctoral thesis supervision

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

IdISBa operates ten scientific-technical platforms (including Biobank, Flow Cytometry, Genomics and Bioinformatics, Microscopy, Proteomics, Clinical Trials Unit UBICEC, Health Information Research PRISIB, and Molecular Imaging PT-IMEM) supporting translational biomedical and health research. It also delivers technology transfer services via UITRI and provides training programs for researchers, healthcare professionals, and graduate students in the Balearic Islands public health system.

Product overview

IdISBa (Institut d'Investigació Sanitària Illes Balears) is a health research institute that provides a comprehensive portfolio of scientific-technical platforms and institutional services to support biomedical and health research in the Balearic Islands. The institute operates as a unified platform consisting of 10 scientific-technical platforms (including Biobank, Genomics and Bioinformatics, Proteomics, Microscopy, and Flow Cytometry) and 7 management areas (including Project Management, Innovation, Training, and Scientific Management). Key platforms include UBICEC for clinical trials, PRISIB for health information research, and PT-IMEM for molecular imaging and mass spectrometry. The institute also provides technology transfer services through UITRI, training programs, and innovation support services for both researchers and companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Biobank Platform A biobank facility for storing and managing biological samples for biomedical research purposes. Serves IdISBa research groups and external institutions requiring biospecimen management.
• Flow Cytometry and Cell Biology Platform Advanced flow cytometry services for cellular analysis and cell biology research, supporting IdISBa-affiliated and external researchers.
• Genomics and Bioinformatics Platform Genomic sequencing and bioinformatics analysis services for biomedical research groups.
• Microscopy Platform Advanced microscopy imaging services for biomedical research applications.
• Proteomics Platform Protein analysis and proteomics research services for biomedical investigators.
• Clinical Research and Clinical Trials Unit (UBICEC) Infrastructure and coordination for conducting clinical trials and clinical research studies in the Balearic Islands healthcare system.
• Health Information Research Platform (PRISIB)

Quantifiable outcome

• 924 research staff members conducting work at the institute
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Six partnerships are on record, tiered core.

• Government of the Balearic Islands - Ministry of Health (Conselleria de Salut)coreStrategic or Co-development PartnerThe parent governmental body to which IdISBa is affiliated as a public foundation within the public sector instrumental entity. Provides institutional oversight, base funding, and strategic direction for the institute's activities.
• University of the Balearic Islands (UIB) - University Institute for Health Sciences ResearchcoreStrategic or Co-development PartnerPrimary academic partner hosting IdISBa's activities on the UIB campus. Provides research staff, doctoral programs, and academic infrastructure including the Margalida Comas Building and Gaspar Melchor de Jovellanos Building for events.
• Son Espases University Hospital (Hospital Universitari Son Espases)coreStrategic or Co-development PartnerMajor teaching hospital hosting IdISBa headquarters and providing clinical research environment. Building S houses the institute's offices. Assembly Hall of Hospital Universitari Son Espases used for conferences.
• Son Llàtzer HospitalcoreStrategic or Co-development PartnerRegional hospital participating in the IdISBa consortium, contributing to clinical research activities across the Balearic Islands healthcare network.
• Primary Health Care Service of Mallorca (Servei de Salut - Atenció Primària de Mallorca)coreStrategic or Co-development PartnerPrimary care service provider integrating community health research into IdISBa's research portfolio, extending the institute's reach into primary care settings.
• Blood and Tissue Bank of the Balearic Islands (Banc de Sang i Teixits de les Illes Balears)coreStrategic or Co-development PartnerHealthcare institution providing blood and tissue banking services supporting biomedical research and clinical applications within the institute's ecosystem.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Institut d'Investigació Biomèdica de Bellvitge (IDIBELL): Spanish public health research institute linked to Bellvitge University Hospital. Operates with the same model — a consortium integrating hospital, primary care, and university research under a single foundation — making it directly comparable in structure, funding mix, and platform portfolio.
• Vall d'Hebron Institut de Recerca (VHIR): Catalan public health research institute affiliated with Vall d'Hebron University Hospital. Comparable in headcount, hospital-anchored model, clinical trials activity, and platform-based service offerings, and a direct competitor for ISCIII and EU funding.
• Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM): Madrid-based health research institute linked to Hospital Gregorio Marañón. Functions under the same Spanish model of accredited health research institutes (Institutos de Investigación Sanitaria), competes with IdISBa for ISCIII accreditation renewals and competitive grants.
• Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS): Barcelona-based health research institute affiliated with Hospital Clínic. Comparable in scale, multi-disciplinary biomedical research, clinical trials volume, and platform infrastructure; frequently listed alongside IdISBa in national IIS benchmarking.
• Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP): Madrid-based health research foundation linked to Hospital La Paz. Operates the same hospital-anchored research foundation model with multiple scientific platforms, and is one of the recognized IIS institutions that IdISBa benchmarks against in ISCIII evaluation cycles.

Broad incumbents

• Centro de Investigación Biomédica en Red (CIBER): National CIBER consortia under Instituto de Salud Carlos III covering multiple disease areas. CIBER functions as a national-level umbrella that IdISBa researchers frequently join as partner groups; competitive in funding capture and a structural reference for how IdISBa could scale.
• Centro Nacional de Investigaciones Cardiovasculares (CNIC): National cardiovascular research center under ISCIII. While focused on a single specialty, it operates with comparable public-foundation governance, competitive grant funding, and platform-based infrastructure; serves as a benchmark for top-tier Spanish biomedical research output.
• Karolinska Institutet: Swedish public medical university and research institute. Comparable as a publicly funded, multi-disciplinary biomedical research organization with clinical trials capacity, though at a substantially larger scale; useful benchmark for institutional governance and HR Excellence practices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/idisbaib
• Facebookfacebook.com/idisbaib

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundació Institut d'Investigació Sanitària Illes Balears